Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Jawad Ahmad, MD Drug-induced liver injury (DILI) is a common problem for patients who take prescription medicine or herbal and dietary supplements. So what resources are available to help reduce this injury? Join Dr. Peter Buch as he speaks with Dr. Jawad Ahmad, Professor of Medicine at Icahn School of Medicine at Mount Sinai, to discuss his study and research on drug-induced liver injury ..read more

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Kenneth Cusi, MD, FACP, FACE From noninvasive tests to liver biopsies—what do we need to know about current diagnostic tools for nonalcoholic steatohepatitis (NASH)? Dr. Charles Turck joins Dr. Kenneth Cusi to dive into diagnostic guidelines and share the latest updates on these tools ..read more

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Paul Kwo, MD Between 2.4 and 4.7 million people have hepatitis C in the United States, but not all have access to proper treatments. So how can clinicians reach more people in the community with this virus? Dr. Peter Buch will give us further insight with Dr. Paul Kwo, Professor of Medicine and the Director of Hepatology at Stanford University ..read more

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Eugenia Shmidt, MD The pregnancy inflammatory bowel disease and neonatal outcomes (PIANO) registry is the largest US-based study that examines pregnant women who have inflammatory bowel disease (IBD). So how can clinicians use the takeaways from this study in their practice? Join Dr. Peter Buch as he discusses IBD in pregnant women with Dr. Eugenia Shmidt, Assistant Professor in the Division of Gastroenterology, Hepatology, and Nutrition at the University of Minnesota ..read more

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Zobair M Younossi MD, MPH, FACP, FACG, AGAF, FAASLD Guest: Scott D. Isaacs, MD FACP, FACE Recently, the American Association of Clinical Endocrinology and the American Association for the Study of Liver Diseases released guideline updates on nonalcoholic steatohepatitis (NASH). How will these updates impact clinical practice? Drs. Zobair M.Younossi and Scott D. Isaacs join Dr. Charles Turck to share their insights on these updated guidelines ..read more

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Miguel Regueiro, MD The horizon for patients with Crohn’s disease is looking promising as new treatments are expected to come out in the next few years. So what are the best practices for treating fistulizing Crohn’s disease? Explore the treatment landscape with Dr. Peter Buch and Dr. Miguel Regueiro, Chair of the Digestive Disease and Surgery Institute at Cleveland Clinic ..read more

Host: Ross M. Maltz, MD Guest: Shail M. Govani, MD, MSc Guest: Nana E. Bernasko, CRNP, WHNP-BC, DNP Guest: Shubha Bhat, PharmD, MS, BCACP As new therapies evolve, including biosimilars, it’s important for clinicians, patients, and caregivers to understand the similarities, differences, and potential risks and benefits of these therapies. Join our panel of experts to find out more about key concepts and best practices to educate your patients ..read more

Host: Ross M. Maltz, MD Guest: Shail M. Govani, MD, MSc Guest: Nana E. Bernasko, CRNP, WHNP-BC, DNP Guest: Shubha Bhat, PharmD, MS, BCACP As new therapies evolve, including biosimilars, it’s important for clinicians, patients, and caregivers to understand the similarities, differences, and potential risks and benefits of these therapies. Join our panel of experts to find out more about key concepts and best practices to educate your patients ..read more

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Bryson Katona, MD, PhD Lynch syndrome is the most common cause of inherited colon cancer and is often underdiagnosed. How can we improve detection of these patients? To find out more, Dr. Peter Buch joins Dr. Bryson Katona from the Hospital of the University of Pennsylvania to explore some key detection strategies ..read more

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Nancy S. Reau, MD The most common liver disease caused by pregnancy is intrahepatic cholestasis of pregnancy (ICP). So what do clinicians need to know to best treat their patients? Explore the impact of liver disease on pregnancy as Dr. Peter Buch is joined by Dr. Nancy S. Reau, Professor in the Department of Internal Medicine at Rush Medical College ..read more